Clare A Balendran

Most-cited papers

1. Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial.

   N. Alkhouri, R. Herring, Heidi Kabler, Z. Kayali +12 more

   2022Journal of Hepatology206 citations Open access

   Semantic Scholar

   Save

2. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications

   Daniel Muthas, A. Reznichenko, Clare A Balendran, Gerhard Böttcher +7 more

   2017Scandinavian Journal of Gastroenterology162 citations

   Semantic Scholar

   Save

3. Identification of the human ApoAV gene as a novel RORα target gene

   U. Lind, T. Nilsson, J. McPheat, P. Strömstedt +3 more

   200527 citations

   Semantic Scholar

   Save

4. Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5‐Lipoxygenase Activating Protein Inhibitor

   H. Ericsson, Karin Nelander, Maria Lagerstrom‐Fermer, Clare A Balendran +10 more

   2018Clinical and Translational Science23 citations Open access

   Semantic Scholar

   Save

5. Identification of the human ApoAV gene as a novel RORalpha target gene.

   U. Lind, T. Nilsson, J. McPheat, P. Strömstedt +3 more

   2005Biochemical and Biophysical Research Communications - BBRC23 citations

   Semantic Scholar

   Save

6. MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?

   S. Whiteoak, A. Claridge, Clare A Balendran, R. Harris +6 more

   2018Inflammatory Bowel Diseases22 citations

   Semantic Scholar

   Save

7. Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies

   K. Randall, Neil Henderson, Jaimini Reens, Sonia Eckersley +6 more

   2016PLoS ONE19 citations Open access

   Semantic Scholar

   Save

8. Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies

   Clare A Balendran, Ann Lövgren, K. Hansson, Karin Nelander +5 more

   2017Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine18 citations Open access

   Semantic Scholar

   Save

9. Determining myeloperoxidase activity and protein concentration in a single assay: Utility in biomarker and therapeutic studies.

   Muir Russell, Nina Prokoph, Neil Henderson, S. Eketjäll +4 more

   2017JIM - Journal of Immunological Methods8 citations

   Semantic Scholar

   Save

10. Preclinical evaluation of point‐of‐care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding

    Clare A Balendran, Neil Henderson, M. Olsson, Ann Lövgren +1 more

    2017Research and Practice in Thrombosis and Haemostasis3 citations Open access

    Semantic Scholar

    Save

11. P2319Initial clinical experience with AZD5718, a novel once daily oral 5-lipoxygenase activating protein (FLAP) inhibitor, intended for patients with coronary artery disease

    S. Skrtic, Clare A Balendran, M. Bhat, Ligia Chialda +9 more

    20170 citations

    Semantic Scholar

    Save